BioSpace News Archive

Lone Star Bio

Astrotech to Demo 1st Detect’s TRACER 1000 to US and Foreign Government Agencies

Astrotech Corporation will demonstrate 1st Detect’s mass spectrometry-based explosives and narcotics detector, the TRACER 1000, at Stand 529 at the Border Security Expo (BSE) in San Antonio, TX from Jan. 31st to Feb. 2nd, 2018.

January 29, 2018
·
2 min read
Biotech Bay

Renevia Data From the Successful Pivotal Trial to Be Presented at the IMCAS Conference

BioTime, Inc. today announced that detailed data from the successful pivotal trial of Renevia in Europe will be presented at the International Master Course on Aging Science (IMCAS) conference on February 3, 2018.

January 29, 2018
·
5 min read
Business

Neuromod Taps World-Renowned Neurostimulation Expert as New CSO

Dr. Lim is a a world-renowned scientist and thought leader in auditory neuroscience, neuroplasticity and neurostimulation.

January 29, 2018
·
2 min read
Pharm Country

Paradigm Spine Announces Landmark Publication of coflex Vs. Decompression Alone in The Journal of Neurosurgery Spine

ESCADA reports a prospective, randomized, controlled, multi-center trial comparing decompression alone to decompression with coflex Interlaminar Stabilization for treatment of moderate to severe lumbar spinal stenosis.

January 29, 2018
·
5 min read
Business

Invitae to Announce Fourth Quarter and Year-End 2017 Financial Results on February 12, 2017

The live webcast of the call may be accessed by visiting the investors section of the company’s website at ir.invitae.com.

January 29, 2018
·
1 min read
Business

Bionik Laboratories Corp. Appoints Andre Auberton-Herve as Chairman of Board of Directors

Auberton-Herve will replace Peter Bloch, who has resigned from his role as Chairman of the Board, effective January 24, 2018. Bloch will remain as a Director.

January 29, 2018
·
5 min read
Business

Mardil Medical Appoints Martin Madden to Board of Directors

A 30-year veteran of Johnson & Johnson’s Research & Development division, Madden has unparalleled experience in bringing exceptional new products and technologies to the market.

January 29, 2018
·
2 min read
FDA

CutisPharma Announces FDA Approval of FIRVANQ for Treatment of Clostridium Difficile Associated Diarrhea (CDAD) and Staphylococcus Aureus Colitis

Upon its launch, which is targeted to be April 2, 2018, FIRVANQ will replace CutisPharma’s FIRST-Vancomycin Unit-of-Use Compounding Kit.

January 29, 2018
·
2 min read
Nordic Nanovector ASA - Allocation of PSUs

The Board of Directors of Nordic Nanovector has on 29th of January 2018 decided to grant 216 550 Performance Share Units to employees in accordance with the authorisation granted at the Extraordinary General Meeting held on 20 December 2017.

January 29, 2018
·
3 min read
Business

Navigant Expands Presence in Berlin

The office will offer the full suite of capabilities of Navigant’s life sciences practice to optimize decision-making at the product, business unit, and enterprise level.

January 29, 2018
·
3 min read